Patent ID: 11903927
Assignee: SCANDION ONCOLOGY A/S
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 0:
1. A method of sensitizing cancer cells of a cancer to an anti-cancer agent or potentiating the therapeutic effect of an anti-cancer agent comprising administering to a subject in need thereof an effective amount of a VRAC modulator and an effective amount of an anti-cancer agent; wherein the cancer is selected from the group consisting of: colorectal cancer, breast cancer, lung cancer (non small cell lung cancer and small cell lung cancer), glioblastomas, head and neck cancers, malignant melanomas, basal cell skin cancer, squamous cell skin cancer, liver cancer, pancreatic cancer, prostate cancer, anal cancer, cervix uteri cancer, bladder cancer, corpus uteri cancer, ovarian cancer, gall bladder cancer, sarcomas, leukemias (myeloid and lymphatic), lymphomas, and myelomatosis.